Featured Research

from universities, journals, and other organizations

Gene may be good target for tough-to-kill prostate cancer cells

Date:
September 28, 2011
Source:
Purdue University
Summary:
Scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells. They are focusing on the function of a gene called Polo-like kinase (Plk1), a critical regulator of the cell cycle. Plk1 is also an oncogene, which tends to mutate and can cause cancer.

Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.

Related Articles


Xiaoqi Liu, an assistant professor of biochemistry and member of Purdue's Center for Cancer Research, and graduate student Shawn Liu are focusing on the function of a gene called Polo-like kinase (Plk1), a critical regulator of the cell cycle. Plk1 is also an oncogene, which tends to mutate and can cause cancer.

The researchers found that later-stage prostate cancer cells are missing Pten, a tumor-suppressor gene. The loss of Pten causes problems during cell division. Instead of the parent cell giving equal copies of DNA to two daughter cells, those new cells receive disproportionate amounts, causing mutations.

"This turns out to be a major driving factor in future cancer," said Xiaoqi Liu, whose findings were published in the Journal of Biological Chemistry. "Without Pten, there is huge potential to become a cancer cell."

When Pten is diminished, the cells become stressed. To compensate, they increase production of Plk1, which causes rapid cell division.

"That's usually a hallmark of cancer formation," Xiaoqi Liu said.

This particular type of later-stage prostate cancer is troublesome because the cells do not respond to drugs aimed at stopping cell division and metastatic cancers spread to other areas. When Pten is missing, Xiaoqi Liu said, those drugs actually increase the production of more Plk1.

To test the theory that Plk1 is a key to cancer formation, the researchers tested a Plk1 inhibitor called BI 2356 on both human cancer cells and mice. In both tests, some cancer cells had Pten present while others had lost it.

In both cases, the cells without Pten responded to the drug.

"In later stages of prostate cancer, cells have lost Pten," Xiaoqi Liu said. "This means the Plk1 inhibitor can be a good drug for treatment of those tumors."

Xiaoqi Liu said tests also showed that BI 2536 could also be effective at low dosages, meaning side effects might be less severe.

Next, the researchers will try to replicate the findings in another mouse model. The National Institutes of Health funded the research.

Contributing to the research were: Timothy Ratliff, the Robert Wallace Miller Director of the Purdue Center for Cancer Research; Stephen Konieczny, a Purdue professor of biological sciences; Bennett Elzey, a Purdue assistant research professor in comparative pathobiology; Bing Song, a Purdue graduate student in biological sciences; Liang Cheng, an Indiana University professor of pathology; and Nihal Ahmad, a University of Wisconsin professor of dermatology.


Story Source:

The above story is based on materials provided by Purdue University. The original article was written by Brian Wallheimer. Note: Materials may be edited for content and length.


Journal Reference:

  1. X. S. Liu, B. Song, B. D. Elzey, T. L. Ratliff, S. F. Konieczny, L. Cheng, N. Ahmad, X. Liu. Polo-like kinase 1 facilitates loss of pten-induced prostate cancer formation. Journal of Biological Chemistry, 2011; DOI: 10.1074/jbc.C111.269050

Cite This Page:

Purdue University. "Gene may be good target for tough-to-kill prostate cancer cells." ScienceDaily. ScienceDaily, 28 September 2011. <www.sciencedaily.com/releases/2011/09/110928125410.htm>.
Purdue University. (2011, September 28). Gene may be good target for tough-to-kill prostate cancer cells. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2011/09/110928125410.htm
Purdue University. "Gene may be good target for tough-to-kill prostate cancer cells." ScienceDaily. www.sciencedaily.com/releases/2011/09/110928125410.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins